Apr 30, 2024
Regulatory press release: Aktieägarna i Chosa Oncology AB, org.nr 559037-2271, kallas till årsstämma fredagen den 31 maj 2024 kl. 13.00 på Medicon Vil...[Read more]
Apr 03, 2024
Regulatory press release: The board of CHOSA Oncology AB (publ) (CHOSA or the Company) has today, 3. April 2024, performed a directed issue of 6 070 2...[Read more]
Regulatory press release: Styrelsen för CHOSA Oncology AB (publ) (CHOSA eller Bolaget) har idag, den 3:e april 2024, genomfört en riktad emission av 6...[Read more]
Mar 28, 2024
Regulatory press release: 28 March 2024 CHOSA Oncology – today announced the appointment of Claus Frisenberg Pedersen as Chief Commercial Officer and...[Read more]
Regulatory press release: Marts 28, 2024 CHOSA Oncology meddelade idag utnämningen av Claus Frisenberg Pedersen som Chief Commercial Officer och Gert...[Read more]
Feb 29, 2024
Regulatory press release: [Read more]
Feb 08, 2024
Regulatory press release: CHOSA Oncology announced today, 8th February 2024, the decision to postpone the release of its interim report for the fourth...[Read more]
Regulatory press release: CHOSA Oncology AB har idag, 8. februari 2024, beslutat att senarelägga publiceringen av delårsrapporten avseende fjärde kvar...[Read more]